Your browser doesn't support javascript.
loading
Conversion therapy for advanced penile cancer with tislelizumab combined with chemotherapy: A case report and review of literature.
Long, Xiang-Yu; Zhang, Shuang; Tang, Lian-Sha; Li, Xiang; Liu, Ji-Yan.
Affiliation
  • Long XY; Department of Oncology, Guang'an People's Hospital, Guang'an 638500, Sichuan Province, China.
  • Zhang S; Department of Biotherapy, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China. 371256871@qq.com.
  • Tang LS; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
  • Li X; Department of Biotherapy, Sichuan University, Chengdu 610041, Sichuan Province, China.
  • Liu JY; Department of Urology, West China Medical School, Sichuan University, Chengdu 610041, Sichuan Province, China.
World J Clin Cases ; 10(33): 12305-12312, 2022 Nov 26.
Article in En | MEDLINE | ID: mdl-36483823
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: World J Clin Cases Year: 2022 Document type: Article Affiliation country: China Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: World J Clin Cases Year: 2022 Document type: Article Affiliation country: China Country of publication: Estados Unidos